Dagu-an, Jeevish .
HRN: 21-84-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/29/2022
09/04/2022
IVT
190mg
Q6
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes